As 2017 promises to be a watershed year for the clinical utility of CRISPR, the 3rd Annual CRISPR Precision Genome Editing Congress Boston will unite large pharma, biotech, leading academia and technology providers. Optimize the adoption of CRISPR gene editing and pioneer further advances within biomedical research, drug discovery, R&D and therapeutic development.
Learn from case study presentations to ensure your CRISPR workflows are customized, minimize off-target effects and overcome key delivery challenges. Join the conversation with market leaders and innovators to cut through the avalanche of publications and extract maximum value from CRISPR genome engineering. Be part of the industry defining meeting to make the most of greatest biotechnological breakthrough in a generation.
"This is designed to describe the profound impact CRISPR is having on basic research and therapeutic development. It will explore what's needed to make the most of this breakthrough technology." Eric Rhodes, Horizon